ContractIntelligence | Misc. Commercialization Agreements

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$40	Subscribers Preview	2002	Agreement for Termination of Development and Commercialization Agreement	Welch Allyn, Inc.	SpectRx, Inc.
$32	Subscribers Preview	2003	Assignment of Commercialization Agreement	Corixa Corp.; Coulter Pharma	Michigan
$45	Subscribers Preview	2002	Collaborative Research, Development and Commercialization Agreement	Hoffmann-La Roche Inc.; Kosan; Brown	Stanford; Cooley Godward
$56	Subscribers Preview	2004	Commercialization Agreement	Vertex Pharmaceuticals Inc.
$53	Subscribers Preview	2004	Estradiol Development and Commercialization Agreement	VIVUS, Inc.
$65	Subscribers Preview	2004	EX-U.S. Commercialization Agreement	Aventis Pharma; Genta	Morgan Lewis
$60	Subscribers Preview	2002	EX-U.S. Commercialization Agreement	Aventis Pharma; Genta	Morgan Lewis
$63	Subscribers Preview	2002	Ex-U.S. Commercialization Agreement	Aventis Pharma; Genta	Morgan Lewis
$55	Subscribers Preview	2003	New Commercialization Agreement	Fuso Pharmaceutical Industries, Ltd.; GenVec	Chase Manhattan
$44	Subscribers Preview	2003	Product Development and Commercialization Agreement	Glaxo Group Ltd.; GlaxoSmithKline	POZEN; Cooley Godward
$52	Subscribers Preview	2004	Testosterone Development and Commercialization Agreement	VIVUS, Inc.
$82	Subscribers Preview	2004	U.S. Commercialization Agreement	Aventis Pharmaceuticals Inc.	Genta Inc.
$76	Subscribers Preview	2002	U.S. Commercialization Agreement	Aventis Pharma; Genta	Morgan Lewis
$71	Subscribers Preview	2002	U.S. Commercialization Agreement	Aventis Pharma; Genta	Morgan Lewis